TABLE 6.

Significantly deregulated microRNAs in serum samples of dilated cardiomyopathy patients detected by the OpenArray® screening compared with healthy donors (left side) and patients with inflammatory and/or virally induced cardiomyopathies (right side)

MiRNA	Fold change	P‐value (−log 10)	MiRNA	Fold change	P‐value (−log 10)
hsa‐miR‐101	3.22	1.81	hsa‐let‐7f	0.33	2.28
hsa‐miR‐106b	2.31	2.73	hsa‐miR‐195	0.41	2.94
HSA‐MIR‐1180	3.38	1.34	hsa‐miR‐21	1.10	1.95
hsa‐miR‐125b	0.57	1.47	hsa‐miR‐30a‐5p	0.67	1.83
hsa‐miR‐130a	2.26	1.47	hsa‐miR‐422a	0.37	1.71
hsa‐miR‐130b	1.87	1.47	hsa‐miR‐590‐5p	0.43	2.48
hsa‐miR‐132	1.66	1.65
hsa‐miR‐140‐3p	3.26	1.98
hsa‐miR‐141	2.75	2.60
hsa‐miR‐146b‐3p	4.25	1.70
hsa‐miR‐155	2.69	1.54
hsa‐miR‐185	1.98	1.62
hsa‐miR‐18a	1.97	2.81
hsa‐miR‐21	1.38	1.76
hsa‐miR‐223	0.29	2.51
hsa‐miR‐23a	2.25	1.71
hsa‐miR‐296	2.10	1.84
hsa‐miR‐30a‐5p	1.66	1.41
hsa‐miR‐30d	2.04	2.06
hsa‐miR‐320	4.13	5.62
HSA‐MIR‐320B	7.64	4.01
hsa‐miR‐323‐3p	5.69	1.70
hsa‐miR‐335	2.14	1.41
hsa‐miR‐363	2.31	1.45
hsa‐miR‐365	0.47	1.91
hsa‐miR‐455	4.02	1.49
hsa‐miR‐486‐3p	10.16	1.86
hsa‐miR‐502	3.42	4.30
hsa‐miR‐502‐3p	3.42	1.35
hsa‐miR‐574‐3p	0.63	2.14
hsa‐miR‐579	2.92	2.16
hsa‐miR‐624	2.28	1.97
hsa‐miR‐885‐5p	0.35	2.08
hsa‐miR‐92a	2.07	1.77
hsa‐miR‐942	1.68	1.43
hsa‐miR‐99a	0.44	1.52
mmu‐miR‐134	2.63	1.45
mmu‐miR‐140	0.55	1.35

Only two microRNAs (miRNAs) (hsa‐miR‐21 and hsa‐miR‐30a‐5p) have been significantly different in dilated cardiomyopathy patients compared with healthy or inflammatory and/or virally induced subjects.